Trisalus Life Sciences, Inc. · NASDAQ:TLSI

Frankenius Equity AB reported a 20.90% stake in Trisalus Life Sciences, Inc. (Schedule 13D/A)

Event Dec 17, 2024 · Filed Dec 19, 2024

Frankenius Equity AB reported a 20.90% stake in Trisalus Life Sciences, Inc., 6,488,719 shares, with active intent on Dec 17, 2024. Filed Dec 19, 2024 (Schedule 13D/A).

Stake
20.90%
Shares
6,488,719
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Frankenius Equity AB20.90%6,488,719
Paul Frankenius20.90%6,488,719

Source

View original at SEC

Related